MALIGNANT HYPERTENSION: A CLINICAL FOLLOW-UP STUDY WITH SPECIAL REFERENCE TO RENAL AND CARDIOVASCULAR FUNCTION AND IMMUNOGENETIC FACTORSGUDBRANDSSON T.1981; ACTA MED. SCAND., SUPPL.; ISSN 0365-463X; SWE; DA. 1981; NO 650; 62 P.; BIBL. 6 P.Article

RENAL FUNCTION AS AN INDICATOR OF PROGNOSIS IN MALIGNANT ESSENTIAL HYPERTENSIONHERLITZ H; GUDBRANDSSON T; HANSSON L et al.1982; SCAND. J. UROL. NEPHROL.; ISSN 0036-5599; SWE; DA. 1982; VOL. 16; NO 1; PP. 51-55; BIBL. 16 REF.Article

MALIGNANT HYPERTENSION: IMPROVING PROGNOSIS IN A RARE DISEASEGUDBRANDSSON T; HANSSON L; HERLITZ H et al.1979; ACTA MED. SCAND.; SWE; DA. 1979; VOL. 206; NO 6; PP. 495-499; BIBL. 17 REF.Article

A HEMODYNAMIC STUDY OF ARTERIOLAR CHANGES IN PATIENTS WITH PREVIOUS MALIGNANT HYPERTENSIONGUDBRANDSSON T; HANSSON L; HERLITZ H et al.1982; ACTA MED. SCAND.; ISSN 0001-6101; SWE; DA. 1982; VOL. 211; NO 6; PP. 443-448; BIBL. 25 REF.Article

HYPERTENSION IN THE ELDERLY: HYPERTENSION SEMINARS AT OESTRA HOSPITAL, GOETEBORG, SWEDENAMERY A; HANSSON L; ANDREN L et al.1981; ACTA MED. SCAND.; ISSN 0001-6101; SWE; DA. 1981; VOL. 210; NO 3; PP. 221-229; BIBL. 63 REF.Article

White coat hypertension : a follow-upJULIUS, S; JAMERSON, K; GUDBRANDSSON, T et al.Clinical and experimental hypertension. Part A, Theory and practice. 1992, Vol 14, Num 1-2, pp 45-53, issn 0730-0077Conference Paper

Metabolic adverse effects of thiazide diuretics : the importance of normokalaemiaANDERSSON, O. K; GUDBRANDSSON, T; JAMERSON, K et al.Journal of internal medicine. Supplement. 1991, Vol 229, Num 735, pp 89-96, issn 0955-7873Article

Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary riskJULIUS, S; GUDBRANDSSON, T.Journal of cardiovascular pharmacology. 1992, Vol 20, pp S40-S48, issn 0160-2446, SUP8Conference Paper

LONG TERM TRIAL OF ATENOLOL IN HYPERTENSIONHANSSON L; HENNINGSEN NC; KARLBERG BE et al.1977; CURR. THERAPEUT. RES.; U.S.A.; DA. 1977; VOL. 22; NO 6 PART. 1; PP. 839-845; BIBL. 12 REF.Article

Erythrocyte sodium transport in malignant hypertensionHERLITZ, H; HILME, E; JONSSON, O et al.Journal of internal medicine. 1990, Vol 228, Num 2, pp 133-137, issn 0954-6820Article

The hemodynamic link between insulin resistance and hypertensionJULIUS, S; GUDBRANDSSON, T; JAMERSON, K et al.Journal of hypertension. 1991, Vol 9, Num 11, pp 983-986, issn 0263-6352Article

Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease : a double-blind, randomized, multicenter studyULVENSTAM, G; DIDERHOLM, E; FRITHZ, G et al.Journal of cardiovascular pharmacology. 1992, Vol 20, pp S67-S73, issn 0160-2446, SUP3Conference Paper

Antihypertensive effect of felodipine of hydralazine when added to β-blocker therapyHANSSON, L; DAHLOF, B; SVENSSON, O et al.Journal of cardiovascular pharmacology. 1988, Vol 12, Num 1, pp 94-101, issn 0160-2446Article